Dr. Jun Yong Ha is the Chief Executive Officer of Seegene USA, Inc., the US subsidiary of Seegene Inc., a global leader in molecular diagnostics that provided over 100M COVID-19 tests to 70 countries worldwide in 2020.
Dr. Ha holds bachelor’s, master’s, and doctoral degrees from Seoul National University in South Korea. He also completed postdoctoral training in Molecular Biology at Princeton University. With extensive expertise in in-vitro diagnostics (IVD), including Product Development, Regulatory Affairs (RAC), and Clinical Affairs, Dr. Ha is a recognized leader in the field.
Since joining Seegene in 2021, Dr. Ha has served as Head of Product Development and Clinical Affairs and Head of Global Business, overseeing operations across North and Latin America.